HCM
MYOK

Highbridge Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Highbridge Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,338
Closed -$136K – 1755
2017
Q1 		$136K Buy
+10,338
New +$132K ﹤0.01% 1359

Other funds holding MYOK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Highbridge Capital Management's MYOK Position: Q2 2017 in Review

Highbridge Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2017, closing a stake of 10,338 shares — an estimated $136K sold.

Highbridge Capital Management first reported a position in MYOK in Q1 2017 and held it in 1 quarter. The position peaked at $136K in Q1 2017. 75 funds tracked by Wall St. Rank hold MYOK as of Q2 2017.

  • Highbridge Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 10,338 MyoKardia, Inc. Common Stock shares in Q2 2017, an estimated $136K.
  • Highbridge Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q1 2017 and held it in 1 quarter.
  • Highbridge Capital Management's MyoKardia, Inc. Common Stock position peaked at $136K in Q1 2017.
  • 75 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2017.

Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.